Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Panic Disorders Market Forecast: What Market Value Is Expected By 2030?

In recent years, the market for panic disorders has experienced robust expansion, projecting a rise from $11.15 billion in 2025 to $11.73 billion in 2026, reflecting a compound annual growth rate of 5.3%. This historical growth trajectory was influenced by factors such as a lack of widespread understanding regarding panic disorders, a prevalent dependence on conventional face-to-face therapeutic approaches, considerable expenses associated with medications, a decentralized mental healthcare system, and limited uptake of digital therapeutic solutions.

The market for panic disorder treatments is projected for considerable expansion over the upcoming years, estimating a reach of $15 billion by 2030 with a CAGR of 6.3%. This projected increase is fueled by a rise in anxiety and panic disorder diagnoses, a greater acceptance of telepsychiatry services, innovations in virtual reality and neurofeedback therapeutic approaches, the broader availability through online pharmacies and hospital networks, and a growing need for tailored mental health strategies. Key developments anticipated within this timeframe involve increased utilization of telepsychiatry and mobile mental health platforms, the incorporation of virtual reality for anxiety treatment, more frequent application of biofeedback and neurofeedback methods, a trend towards individualized treatment plans for panic disorders, and an overall enhancement of mental healthcare infrastructure and hospital-based offerings.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13191&type=smp

Panic Disorders Market Development Factors: Which Trends Are Supporting Demand?

The expanding adoption of remote healthcare solutions is anticipated to be a key driver for the advancement of the panic disorders market in the future. Telehealth, which encompasses the delivery of health services and medical advice from a distance through electronic means like video calls, phone conversations, and encrypted messaging, plays a significant role in this trend by enabling mental health professionals to deliver psychotherapy and counseling to individuals experiencing panic disorders. These remote sessions can take various forms, including one-on-one therapy, group discussions, or support forums, all conducted through secure video conferencing technology. Illustrating this trend, data from FAIR Health Inc. in April 2023 revealed a nationwide uptick in telehealth engagement, with its proportion among medical claim lines climbing from 5.5% in December 2022 to 5.9% in January 2023, marking a 7.3% increase. Consequently, the growing incorporation of telehealth services is directly contributing to the expansion of the panic disorders market.

Panic Disorders Market Segment Analysis And Revenue Opportunities

The panic disorders market covered in this report is segmented –

1) By Treatment Type: Pharmacotherapies, Psychotherapeutic Interventions, Digital Or Tech-Enabled Therapies

2) By Disorder Type: Panic Disorder Without Agoraphobia, Panic Disorder With Agoraphobia, Mild Panic Disorder, Moderate Panic Disorder, Severe Panic Disorder, Panic Disorder With Comorbidities

3) By Age Group: Children And Adolescents, Adults, Elderly

4) By End User: Hospitals, Specialty Mental Health Clinics, Primary Care Clinics, Telehealth And Digital Platforms, Home Healthcare Services

Subsegments:

1) By Pharmacotherapies: Antidepressants, Benzodiazepines, Beta-Blockers

2) By Psychotherapeutic Interventions: Cognitive Behavioral Therapy (CBT), Exposure Therapy, Psychodynamic Therapy, Group And Family Therapy

3) By Digital Or Tech-Enabled Therapies: Mental Health Apps, Telepsychiatry Or Teletherapy, Virtual CBT Programs

Panic Disorders Market Transformation Trends: Which Innovations Are Driving Change?

The primary participants in the panic disorder market are actively engaged in the creation of sophisticated therapeutic options, exemplified by extended-release capsules, as a strategy to secure their competitive standing. These extended-release capsules are engineered to progressively dispense their therapeutic components over an extended duration, spanning typically twelve to twenty-four hours, thereby addressing medical needs that necessitate sustained medication delivery. Illustrating this trend, in May of 2023, the pharmaceutical firm Granules India Ltd., headquartered in India, obtained approval for their abbreviated new drug application (ANDA) from the United States Food & Drug Administration (USFDA) for venlafaxine hydrochloride extended-release capsules, which have been shown to be bioequivalent to the Effexor XR Extended-Release Capsules, the reference-listed drug product manufactured by Upjohn US 2 LLC. This medication, venlafaxine HCl extended-release capsules, is indicated for the treatment of several conditions, encompassing generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD), by enhancing neurotransmitter levels of serotonin and norepinephrine within the brain, with initial dosages commonly set at 75 mg daily, subject to upward adjustment by a healthcare provider based on patient requirements.

Panic Disorders Market Leading Players Shaping Industry Direction

Major companies operating in the panic disorders market are F. Hoffmann‑La Roche Ltd, Sanofi S.A, Bristol‑Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd, Mylan N.V., Pfizer Inc, Sun Pharmaceutical Industries Ltd, H. Lundbeck A/S, Neurocrine Biosciences Inc, Neuraxpharm, Actavis Plc, Sumitomo Pharma Co Ltd, LIFECARE NEURO PRODUCTS LTD, Merck & Co Inc, Johnson & Johnson, Novartis AG, Otsuka Pharmaceutical Co Ltd.

Access The Complete Panic Disorders Market Report:

https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

Panic Disorders Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the panic disorders market in 2025. Asia Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model